EUVIMEDEUVIMED entdecken
Crossref

Characterization of a Novel, Recurrent 40.6 kb α 0 ‐Thalassemia Deletion in Canadians of East Indian Descent

John S Waye iD, Meredith Hanna, Betty-Ann Hohenadel, Lisa Nakamura, Lynda Walker, Landry E Nfonsam iD, Heli Yadav, Barry Eng

International Journal of Laboratory Hematology · 03.11.2026

DOI: 10.1111/ijlh.70273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 03.11.2026. Verfasst von John S Waye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Genetics Laboratory, Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences, Hamilton, Ontario, Canada. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Large α 0 ‐thalassemia deletions involving both HBA1 and HBA2 genes are rare in South Asian populations and remain under‐characterized. We describe a novel 40.6 kb α 0 ‐thalassemia deletion identified in multiple unrelated Canadians of East Indian descent and assess its molecular and clinical significance.

Methods

Individuals with suspected α‐thalassemia trait were identified by complete blood count and hemoglobin analysis. Samples with microcytosis and/or hypochromia and normal Hb A 2 underwent molecular testing, including gap‐PCR for common deletions, Sanger sequencing, and multiplex ligation‐dependent probe amplification. Deletion breakpoints were defined by targeted PCR and Sanger sequencing. A specific gap‐PCR assay was developed for rapid detection, and retrospective screening was performed.

Results

Twelve unrelated carriers of a 40.6 kb deletion removing HBZ , HBA2 , and HBA1 were identified. All showed hematologic features consistent with α‐thalassemia trait (MCV 65.4 ± 3.6 fL, MCH 20.2 ± 1.1 pg, normal Hb A 2 ). Breakpoint analysis demonstrated non‐homologous recombination between Alu elements. Recurrence among individuals of similar ancestry suggests a founder effect. We identified two couples at 25% risk for having children with Hb H disease due to compound heterozygosity for the 40.6 kb deletion and α + ‐thalassemia mutations, and diagnosed two Hb H disease patients with genotypes involving the 40.6 kb deletion.

Conclusions

This novel α 0 ‐thalassemia deletion is a recurrent and likely under‐recognized cause of α‐thalassemia and Hb H disease in individuals of East Indian ancestry, underscoring the need for population‐specific molecular testing strategies.

Schlagwörter

Stichwörter der Autor:innen

Hb H diseaseIndiaPunjabnovel deletionα0‐thalassemia

Autor:innen und Institutionen

  • Molecular Genetics Laboratory, Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.

ORCID-Profile: John S Waye, Landry E Nfonsam

Zitieren

APA

Waye, J. S., Hanna, M., Hohenadel, B. A., Nakamura, L., Walker, L., Nfonsam, L. E., Yadav, H., & Eng, B. (2026). Characterization of a Novel, Recurrent 40.6 kb α 0 ‐Thalassemia Deletion in Canadians of East Indian Descent. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.70273

Vancouver

Waye JS, Hanna M, Hohenadel BA, Nakamura L, Walker L, Nfonsam LE, et al. Characterization of a Novel, Recurrent 40.6 kb α 0 ‐Thalassemia Deletion in Canadians of East Indian Descent. International Journal of Laboratory Hematology. 2026. doi:10.1111/ijlh.70273

BibTeX
@article{Waye2026,
  author = {Waye, John S and Hanna, Meredith and Hohenadel, Betty-Ann and Nakamura, Lisa and Walker, Lynda and Nfonsam, Landry E and Yadav, Heli and Eng, Barry},
  title = {Characterization of a Novel, Recurrent 40.6 kb α 0 ‐Thalassemia Deletion in Canadians of East Indian Descent},
  journal = {International Journal of Laboratory Hematology},
  year = {2026},
  doi = {10.1111/ijlh.70273}
}
Kostenlos starten →